Cargando…
Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats
BACKGROUND: This study aimed to explore the effects of Kangdaxin oral liquid on myocardial fibrosis in heart failure with preserved ejection fraction (HFpEF) rats. METHODS: A total of 30 Sprague Dawley (SD) rats were randomly divided into 3 groups Sham operation group (Sham), HFpEF group (HFpEF), an...
Autores principales: | Wu, Xiang, Zhang, Tingting, Qiao, Jianfeng, Li, Cuiyun, Lin, Chao, Xiong, Shangquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096319/ https://www.ncbi.nlm.nih.gov/pubmed/35572890 http://dx.doi.org/10.21037/jtd-22-198 |
Ejemplares similares
-
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018) -
Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2013) -
Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
por: Lewis, Gavin A., et al.
Publicado: (2022) -
Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013) -
Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)